Form 8-K - Current report:
SEC Accession No. 0001628280-24-042833
Filing Date
2024-10-15
Accepted
2024-10-15 16:11:54
Documents
28
Period of Report
2024-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-20241015.htm   iXBRL 8-K 38393
2 EX-10.1 c4tfisherconsultingagree.htm EX-10.1 4009
3 EX-99.1 cccc-20241015xexx991.htm EX-99.1 16531
7 c4tfisherconsultingagree001.jpg GRAPHIC 208363
8 c4tfisherconsultingagree002.jpg GRAPHIC 235330
9 c4tfisherconsultingagree003.jpg GRAPHIC 248676
10 c4tfisherconsultingagree004.jpg GRAPHIC 265816
11 c4tfisherconsultingagree005.jpg GRAPHIC 221927
12 c4tfisherconsultingagree006.jpg GRAPHIC 250096
13 c4tfisherconsultingagree007.jpg GRAPHIC 254758
14 c4tfisherconsultingagree008.jpg GRAPHIC 202704
15 c4tfisherconsultingagree009.jpg GRAPHIC 42300
16 c4tfisherconsultingagree010.jpg GRAPHIC 122487
17 c4tfisherconsultingagree011.jpg GRAPHIC 27029
18 c4tfisherconsultingagree012.jpg GRAPHIC 27536
19 c4tlogo1.jpg GRAPHIC 8913
  Complete submission text file 0001628280-24-042833.txt   3111505

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20241015.xsd EX-101.SCH 1948
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20241015_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20241015_pre.xml EX-101.PRE 13088
30 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20241015_htm.xml XML 2818
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 241371958
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)